2024年4月27日 · Acute myeloid leukemia (AML) is a rapidly progressing myeloid neoplasm characterized by the clonal expansion of immature myeloid-derived cells, known as blasts, in …

Herein, we have established the effect of phosphate buffered saline (PBS) washing on AML patient samples stored in media. Although PBS washes effectively removed serum and blood …

Choosing the appropriate cell line for acute myeloid leukemia (AML) research is crucial for obtaining reliable and relevant results. Several factors should be considered when selecting a …

2022年5月9日 · Here, we show decreased diversity in the gut microbiota of AML patients or murine models. Gut microbiota dysbiosis induced by antibiotic treatment accelerates murine …

Background: Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults; AML is highly heterogeneous and involves abnormalities at multiple omics levels. Small non-coding …

2021年10月28日 · Disease relapse remains common following treatment of acute myeloid leukemia (AML) and is due to chemoresistance of leukemia cells with disease repopulating …

Acute myeloid leukaemia (AML) frequently affects older adults who are unsuitable for intensive therapies and is often associated with a poor prognosis and short survival. Azacitidine and …

Treatment access: Some recommended AML treatments currently require individual hospital approval, leading to variation in availability.For example, CPX-351 and gemtuzumab …

The PBS subsidises treatment with azacitidine (tablet) and decitabine+cedazuridine under the National Health Act, section 85 for patients with AML. Patients must be eligible for the PBS …

2025年3月1日 · Background Acute myeloid leukemia (AML) is a prevalent malignancy of the hematologic system. Despite advancements in therapeutic approaches, significant …